Stanley Ballou is a Rheumatology/Immunology physician affiliated with Case Western Reserve University. OpenAlex indexes 45 publications with 1,685 citations (h-index 19); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2500 Metrohealth Dr
Cleveland, OH 441091900
Telephone
216-778-7800Registry record last updated 22 Dec 2021.
Clinical trials
- Pentoxifylline in Lupus Nephritis
Sponsor: MetroHealth Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year20221 payment
- Amgen Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
38.4%Folate Analog Metabolic Inhibitor17.8%Methotrexate95%Rasuvo5%Part D<11 patientsTNF inhibitor8%Humira(Cf) Pen29%Humira(Cf)25%Enbrel Sureclick19%Humira Pen12%Cimzia (2 Pack)8%Humira8%Part D<11 patients+ 6 more classes in this area
Antiparasitic
22%Antimalarial22%Hydroxychloroquine Sulfate100%Part D≥108 patientsMetabolism & gastrointestinal
14.7%Corticosteroid11.1%Prednisone100%Part D≥56 patientsAminosalicylate2%Sulfasalazine100%Part D≥13 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 1985–2002 per NIH RePORTER. The latest:
- REPEATED DOSES OF LPJ-394 IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Case Western Reserve University
FY2002M01RR000080 - An open label of LJP394 in patients with systemic lupus erythematosus
Case Western Reserve University
FY2002M01RR000080 - Tolerability &effectiveness of rofecoxib vs naproxen
Case Western Reserve University
FY2002M01RR000080
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Reliability of C-reactive protein as an inflammatory marker in patients with immune-mediated inflammatory diseases and liver dysfunction
Rheumatology Advances in Practice
2023 - Association of hidradenitis suppurativa with autoimmune disease and autoantibodies
Rheumatology Advances in Practice
2021 - Incidence of blindness in a population of rheumatic patients treated with hydroxychloroquine
Rheumatology Advances in Practice
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Peter Whitehouse, MD
Case Western Reserve University
Alvin Schmaier, MD
Case Western Reserve University
Stuart Youngner, MD
Case Western Reserve University
Max Wiznitzer, MD
Case Western Reserve University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”